Showing results (481-490 of 1,014) with videos related to

Sort By:
Pageof 102
Lancet (London, England)|September 11, 1982
Scope of a technique for electrical stimulation of human brain, spinal cord, and muscleP A Merton, D K Hill, H B Morton, et al.
Behavioural Neurology|February 4, 2014
Contact with a nurse practitioner: a short-term evaluation study in Parkinson's disease and dystoniaM Jahanshahi, R G Brown, C Whitehouse, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1986
Electrophysiological and positron emission studies in a patient with cortical myoclonus, epilepsia partialis continua and motor epilepsyJ M Cowan, J C Rothwell, R J Wise, et al.
Lancet (London, England)|September 6, 1975
Manipulation of brain serotonin in the treatment of myoclonusD Chadwick, P Jenner, R Harris, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1974
Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's diseaseJ D Parkes, R C Baxter, C D Marsden, et al.
Neurology|May 1, 1976
Primary sensory symptoms in parkinsonismS R Snider, S Fahn, W P Isgreen, et al.
Journal of Pharmaceutical Sciences|November 1, 1984
Synthesis and dopaminergic activity of 3-(3,4-dihydroxyphenyl)-1-n-propylpyrrolidine hydrobromideA M Crider, T F Hemdi, M N Hassan, et al.
Annals of Neurology|October 1, 1996
Diagnostic guidelines in central nervous system Whipple's diseaseE D Louis, T Lynch, P Kaufmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1995
Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body diseaseE D Louis, J E Goldman, J M Powers, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 1, 1993
Therapeutic trial of milacemide in patients with myoclonus and other intractable movement disordersM F Gordon, R Diaz-Olivo, A L Hunt, et al.
Pageof 102